siRNA, Anti-TAF1L, 2'-OMe/2'-MOE/Ribo/Backbone-modified(CAT#: SIRGT56442WQ-2OMe)

The product SIRGT56442WQ-2OMe is a type of small interfering RNA (siRNA) that targets TAF1L gene and regulates the expression of gene. The siRNA interferes with the expression of TAF1L gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_153809.2
Alternative Names TAF(II)210; TAF2A2
Related Diseases Dystonia 3
Purification HPLC
Target Gene
Gene ID 138474
Uniprot ID Q8IZX4
Sub Cat Target Species Modification Scale  
SIRGT58442WQ-2MOE TAF1L Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT56442WQ-RB TAF1L Human Ribo-modified Inquiry
SIRGT57442WQ-BB TAF1L Human Backbone-modified Inquiry

Related Products